search
Back to results

The Effect of the Fermented Tea Beverage Kombucha on the Oral and Gut Microflora

Primary Purpose

Microbial Colonization

Status
Completed
Phase
Not Applicable
Locations
Sweden
Study Type
Interventional
Intervention
Consumption of kombucha
Consumption of heat-sterilized kombucha
Sponsored by
Lund University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Microbial Colonization focused on measuring Microbiota colonization kombucha bacteria yeast

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • The participants should be above 18 years of age.
  • The participants must live in proximity of Lund or Helsingborg to be able to leave samples collected.
  • The participants should consider themselves healthy and have no gut or stomach problems.

Exclusion Criteria:

  • The participants should not be diagnosed with any gut or stomach diseases or problems.
  • The participants cannot consume any food with living microorganisms two weeks before, during of ten days after the intervention.
  • Participants cannot use anti-microbial oral products during the study.

Sites / Locations

  • Lund University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Placebo Comparator

No Intervention

Arm Label

Living kombucha

Heat-sterilized kombucha

Water

Arm Description

Outcomes

Primary Outcome Measures

The primary outcome is a change in the composition of the gut of oral micro flora, measured by extraction and sequencing of genetic material in fecal and saliva samples.
A library will be created using Illumina sequencing that will enable comparing the microbiological composition before and after the intervention.

Secondary Outcome Measures

The secondary outcome of the study is to be able to re-isolate a species from the kombucha in the collected samples after the intervention.
The secondary outcome will be measured by comparing results from the sequencing of microbes in the collected human samples and from the kombucha drink itself.

Full Information

First Posted
March 11, 2019
Last Updated
March 12, 2019
Sponsor
Lund University
search

1. Study Identification

Unique Protocol Identification Number
NCT03873350
Brief Title
The Effect of the Fermented Tea Beverage Kombucha on the Oral and Gut Microflora
Official Title
The Effect of the Fermented Tea Beverage Kombucha on the Human Microflora: a Placebo-controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
April 1, 2018 (Actual)
Primary Completion Date
May 2, 2018 (Actual)
Study Completion Date
May 4, 2018 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Lund University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the project is to investigate if consumption of the fermented tea beverage kombucha has an effect on the gut and/or oral microbiota, and further if it depends on the content of living bacteria or is inherent even to sterilized kombucha. This will be studied by a clinical trial in which healthy individuals will be given living kombucha, sterilized kombucha or water. The participants will consume one bottle (33 cl) of their designated drink per day for 21 days. Fecal and saliva samples will be collected before, directly and ten days after the intervention. These will then be examined to see if there is a change in the micro flora due to the kombucha.
Detailed Description
The first part of the project focuses on studying the characteristics of the kombucha drink and microbial composition. The amount of living organisms in the drink will be determined by colony count. Apart from this, the culture will be studied to determine which organisms are present and which are dominant. After isolation of colonies found from culturing, Sanger sequencing will be used for characterization. The second part, which consists of the human study, will be performed over a span of 3 weeks and the aim is that 60 persons take part. The participants should be healthy, and have no diagnosed gut or stomach problems, and be 18 years old or older. They will be divided into groups, where one will be given living kombucha, one group kombucha sterilized by boiling (placebo) and the final group plain water (control group). The participants will drink one bottle (33 cl) of their designated beverage daily for two weeks. Fecal and saliva samples will be collected before, directly after and 10 days after the intervention. The samples will then be studied by sequencing the present organisms, after having extracted them. The library preparation will be made using Illumina sequencing. If possible, the aim is also to re-isolate a species from the kombucha after the study. The participants will be registered for the study as they sign a consent form. These forms will then be treated as confidential material, and therefore be kept locked away at the institution. Only participating researchers will have access to the forms. The participants will store the samples collected during the study until they are handed in for analysis. The samples will be destroyed during analysis. The sample size has been chosen to a maximum of 60 participants, due to economical boundaries, but mainly because similar studied have used even fewer participants. As this is a pilot study more is not necessary. The intervention time (three weeks) was determined by comparison to other studies, but also restricted by the time scope of the project.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Microbial Colonization
Keywords
Microbiota colonization kombucha bacteria yeast

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The participants will be divided into three groups in which one is given living kombucha, one heat-sterilized kombucha (placebo group) and one regular tap water (control group).
Masking
ParticipantInvestigator
Masking Description
The participants will be masked, meaning they will not know if they are given living or sterilized kombucha. The control group consuming water will know that they are the control group.
Allocation
Randomized
Enrollment
42 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Living kombucha
Arm Type
Experimental
Arm Title
Heat-sterilized kombucha
Arm Type
Placebo Comparator
Arm Title
Water
Arm Type
No Intervention
Intervention Type
Other
Intervention Name(s)
Consumption of kombucha
Intervention Description
The intervention performed in the study implies letting healthy individuals consume one bottle (33 cl) of living kombucha daily for three weeks.
Intervention Type
Other
Intervention Name(s)
Consumption of heat-sterilized kombucha
Intervention Description
The intervention performed in the study implies letting healthy individuals consume one bottle (33 cl) of heat-sterilized kombucha daily for three weeks.
Primary Outcome Measure Information:
Title
The primary outcome is a change in the composition of the gut of oral micro flora, measured by extraction and sequencing of genetic material in fecal and saliva samples.
Description
A library will be created using Illumina sequencing that will enable comparing the microbiological composition before and after the intervention.
Time Frame
Samples will be collected before, directly after and ten days after the end of the intervention.
Secondary Outcome Measure Information:
Title
The secondary outcome of the study is to be able to re-isolate a species from the kombucha in the collected samples after the intervention.
Description
The secondary outcome will be measured by comparing results from the sequencing of microbes in the collected human samples and from the kombucha drink itself.
Time Frame
Samples will be collected before, directly after and ten days after the intervention. The kombucha culture is studied before the intervention.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: The participants should be above 18 years of age. The participants must live in proximity of Lund or Helsingborg to be able to leave samples collected. The participants should consider themselves healthy and have no gut or stomach problems. Exclusion Criteria: The participants should not be diagnosed with any gut or stomach diseases or problems. The participants cannot consume any food with living microorganisms two weeks before, during of ten days after the intervention. Participants cannot use anti-microbial oral products during the study.
Facility Information:
Facility Name
Lund University
City
Lund
State/Province
Skåne
ZIP/Postal Code
22100
Country
Sweden

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
No plan to share participant data.

Learn more about this trial

The Effect of the Fermented Tea Beverage Kombucha on the Oral and Gut Microflora

We'll reach out to this number within 24 hrs